APA

Jernström S., Hongisto V., Leivonen S., Due E. U., Tadele D. S., Edgren H., Kallioniemi O., Perälä M., Mælandsmo G. M. & Sahlberg K. K. (2017). Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. : Breast cancer (Dove Medical Press).

Chicago

Jernström Sandra, Hongisto Vesa, Leivonen Suvi-Katri, Due Eldri Undlien, Tadele Dagim Shiferaw, Edgren Henrik, Kallioniemi Olli, Perälä Merja, Mælandsmo Gunhild Mari and Sahlberg Kristine Kleivi. 2017. Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. : Breast cancer (Dove Medical Press).

Harvard

Jernström S., Hongisto V., Leivonen S., Due E. U., Tadele D. S., Edgren H., Kallioniemi O., Perälä M., Mælandsmo G. M. and Sahlberg K. K. (2017). Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. : Breast cancer (Dove Medical Press).

MLA

Jernström Sandra, Hongisto Vesa, Leivonen Suvi-Katri, Due Eldri Undlien, Tadele Dagim Shiferaw, Edgren Henrik, Kallioniemi Olli, Perälä Merja, Mælandsmo Gunhild Mari and Sahlberg Kristine Kleivi. Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. : Breast cancer (Dove Medical Press). 2017.